These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32418842)

  • 21. An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents.
    Lewis CP; Port JD; Frye MA; Vande Voort JL; Ameis SH; Husain MM; Daskalakis ZJ; Croarkin PE
    Front Neural Circuits; 2016; 10():98. PubMed ID: 27965544
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.
    Milak MS; Rashid R; Dong Z; Kegeles LS; Grunebaum MF; Ogden RT; Lin X; Mulhern ST; Suckow RF; Cooper TB; Keilp JG; Mao X; Shungu DC; Mann JJ
    JAMA Netw Open; 2020 Aug; 3(8):e2013211. PubMed ID: 32785636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study.
    Rosenberg DR; Macmaster FP; Mirza Y; Smith JM; Easter PC; Banerjee SP; Bhandari R; Boyd C; Lynch M; Rose M; Ivey J; Villafuerte RA; Moore GJ; Renshaw P
    Biol Psychiatry; 2005 Nov; 58(9):700-4. PubMed ID: 16084860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of hippocampal N-acetyl-aspartate in youth with treatment resistant major depression.
    Lefebvre D; Langevin LM; Jaworska N; Harris AD; Lebel RM; Jasaui Y; Kirton A; Wilkes TC; Sembo M; Swansburg R; MacMaster FP
    J Affect Disord; 2017 Jan; 207():110-113. PubMed ID: 27721183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.
    Abdallah CG; De Feyter HM; Averill LA; Jiang L; Averill CL; Chowdhury GMI; Purohit P; de Graaf RA; Esterlis I; Juchem C; Pittman BP; Krystal JH; Rothman DL; Sanacora G; Mason GF
    Neuropsychopharmacology; 2018 Sep; 43(10):2154-2160. PubMed ID: 29977074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.
    Murck H; Schubert MI; Schmid D; Schüssler P; Steiger A; Auer DP
    J Psychiatr Res; 2009 Jan; 43(3):175-80. PubMed ID: 18533184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
    Yildiz-Yesiloglu A; Ankerst DP
    Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
    Auer DP; Pütz B; Kraft E; Lipinski B; Schill J; Holsboer F
    Biol Psychiatry; 2000 Feb; 47(4):305-13. PubMed ID: 10686265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
    Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
    JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered neurometabolism in major depressive disorder: A whole brain
    Kahl KG; Atalay S; Maudsley AA; Sheriff S; Cummings A; Frieling H; Schmitz B; Lanfermann H; Ding XQ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109916. PubMed ID: 32169561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis: Exposure to Early Life Stress and Risk for Depression in Childhood and Adolescence.
    LeMoult J; Humphreys KL; Tracy A; Hoffmeister JA; Ip E; Gotlib IH
    J Am Acad Child Adolesc Psychiatry; 2020 Jul; 59(7):842-855. PubMed ID: 31676392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of glutamate and cortical thickness is restricted to regions subserving trait but not state markers in major depressive disorder.
    Li M; Metzger CD; Li W; Safron A; van Tol MJ; Lord A; Krause AL; Borchardt V; Dou W; Genz A; Heinze HJ; He H; Walter M
    J Affect Disord; 2014 Dec; 169():91-100. PubMed ID: 25173431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamatergic system abnormalities in posttraumatic stress disorder.
    Nishi D; Hashimoto K; Noguchi H; Hamazaki K; Hamazaki T; Matsuoka Y
    Psychopharmacology (Berl); 2015 Dec; 232(23):4261-8. PubMed ID: 26292802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.
    Rosenberg DR; Mirza Y; Russell A; Tang J; Smith JM; Banerjee SP; Bhandari R; Rose M; Ivey J; Boyd C; Moore GJ
    J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1146-53. PubMed ID: 15322418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.
    Block W; Träber F; von Widdern O; Metten M; Schild H; Maier W; Zobel A; Jessen F
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):415-22. PubMed ID: 18845018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.
    Abdallah CG; Niciu MJ; Fenton LR; Fasula MK; Jiang L; Black A; Rothman DL; Mason GF; Sanacora G
    Psychother Psychosom; 2014; 83(5):298-307. PubMed ID: 25116726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variant in SLC1A2 is associated with elevated anterior cingulate cortex glutamate and lifetime history of rapid cycling.
    Veldic M; Millischer V; Port JD; Ho AM; Jia YF; Geske JR; Biernacka JM; Backlund L; McElroy SL; Bond DJ; Villaescusa JC; Skime M; Choi DS; Lavebratt C; Schalling M; Frye MA
    Transl Psychiatry; 2019 May; 9(1):149. PubMed ID: 31123248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences.
    Kuehl LK; Deuter CE; Hellmann-Regen J; Kaczmarczyk M; Otte C; Wingenfeld K
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109751. PubMed ID: 31446157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo.
    Das P; Tanious M; Fritz K; Dodd S; Dean OM; Berk M; Malhi GS
    Aust N Z J Psychiatry; 2013 Apr; 47(4):347-54. PubMed ID: 23341476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 13C magnetic resonance spectroscopy studies of alterations in glutamate neurotransmission.
    Shen J
    Biol Psychiatry; 2006 May; 59(10):883-7. PubMed ID: 16199016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.